Utilize este identificador para referenciar este registo: http://hdl.handle.net/10400.16/2157
Registo completo
Campo DCValorIdioma
degois.publication.firstPage703pt_PT
degois.publication.issue11pt_PT
degois.publication.lastPage708pt_PT
degois.publication.locationSpainpt_PT
degois.publication.titleRevista Espanola de Enfermedades Digestivaspt_PT
dc.relation.publisherversionhttps://online.reed.es/Revistas/REED_2016_108_11/Contenido/pdf/vol108num11_en_4.pdfpt_PT
dc.contributor.authorTeles-Sampaio, E.-
dc.contributor.authorMaia, L.-
dc.contributor.authorSalgueiro, P.-
dc.contributor.authorMarcos-Pinto, R.-
dc.contributor.authorDinis-Ribeiro, M.-
dc.contributor.authorPedroto, I.-
dc.date.accessioned2017-07-24T13:55:29Z-
dc.date.available2017-07-24T13:55:29Z-
dc.date.issued2016-11-
dc.identifier.citationRev Esp Enferm Dig. 2016 Nov;108(11):703-708pt_PT
dc.identifier.issn1130-0108-
dc.identifier.urihttp://hdl.handle.net/10400.16/2157-
dc.description.abstractBACKGROUND: Nonvariceal upper gastrointestinal bleeding emerges as a major complication of using antiplatelet agents and/or anticoagulants and represents a clinical challenge in patients undergoing these therapies. AIM: To characterize patients with nonvariceal upper gastrointestinal bleeding related to antithrombotics and their management, and to determine clinical predictors of adverse outcomes. METHODS: Retrospective cohort of adults who underwent upper gastrointestinal endoscopy after nonvariceal upper gastrointestinal bleeding from 2010 to 2012. The outcomes were compared between patients exposed and not exposed to antithrombotics. RESULTS: Five hundred and forty-eight patients with nonvariceal upper gastrointestinal bleeding (67% men; mean age 66.5 ± 16.4 years) were included, of which 43% received antithrombotics. Most patients had comorbidities. Peptic ulcer was the main diagnosis and endoscopic therapy was performed in 46% of cases. The 30-day mortality rate was 7.7% (n = 42), and 36% were bleeding-related. The recurrence rate was 9% and 14% of patients with initial endoscopic treatment needed endoscopic retreatment. There were no significant differences between the exposed and non-exposed groups in most outcomes. Co-morbidities, hemodynamic instability, high Rockall score, low hemoglobin (7.76 ± 2.72 g/dL) and higher international normalized ratio (1.63 ± 1.13) were associated significantly with mortality in a univariate analysis. CONCLUSIONS: Adverse outcomes were not associated with antithrombotic use. The management of nonvariceal upper gastrointestinal bleeding constitutes a challenge to clinical performance optimization and clinical cooperation.pt_PT
dc.language.isoengpt_PT
dc.publisherAran Edicionespt_PT
dc.rightsopenAccesspt_PT
dc.subjectAnticoagulantspt_PT
dc.subjectComorbiditypt_PT
dc.subjectEndoscopypt_PT
dc.subjectGastrointestinapt_PT
dc.subjectGastrointestinal hemorrhagept_PT
dc.subjectOutcome assessment.pt_PT
dc.subjectPlatelet aggregation inhibitorspt_PT
dc.titleAntiplatelet agents and/or anticoagulants are not associated with worse outcome following nonvariceal upper gastrointestinal bleedingpt_PT
dc.typearticlept_PT
dc.description.versioninfo:eu-repo/semantics/publishedVersionpt_PT
dc.peerreviewedyespt_PT
degois.publication.volume108pt_PT
dc.identifier.doi10.17235/reed.2016.4424/2016pt_PT
Aparece nas colecções:SN - Artigos publicados em revistas indexadas na Medline
SG - Artigos publicados em revistas indexadas na Medline

Ficheiros deste registo:
Ficheiro Descrição TamanhoFormato 
Antiplatelet agents.pdf627,4 kBAdobe PDFVer/Abrir


FacebookTwitterDeliciousLinkedInDiggGoogle BookmarksMySpace
Formato BibTex MendeleyEndnote Degois 

Todos os registos no repositório estão protegidos por leis de copyright, com todos os direitos reservados.